B01D 15/3819
Of the nucleic acid-nucleic acid binding protein type
Official title: {of the nucleic acid-nucleic acid binding protein type}
B01D15/3819 (Of the nucleic acid-nucleic acid binding protein type) appears on 16 US grants and 36 published applications in this corpus.
Search patents in B01D- Granted patents
- 16
- Published applications
- 36
- Assignees
- 27
- Inventors
- 94
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 5 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 2 | 1 |
| 2020 | 3 | 3 |
| 2021 | 0 | 4 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 3 | 4 |
| 2025 | 2 | 5 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Relative potency assay for viral vector encoding isomerohydrolases15 Jul 2025US 12,359,239 B2Spark Therapeutics, Inc.
- Manufacturing method of the operation pipe1 Apr 2025US 12,263,489 B2Shimadzu Corporation
- Methods for ethanol-free mRNA purification29 Oct 2024US 12,129,460 B2Sanofi
- Chromatography medium27 Aug 2024US 12,070,735 B2Puridify Ltd.
- Methods for targeted protein quantification by bar-coding affinity reagent with unique DNA sequences9 Jul 2024US 12,030,909 B2Arizona Board of Regents on behalf of Arizona State University
- Multicistron expression vector for covid-19 vaccine11 Jun 2026US 2026/0159553 A1Kashiv Biosciences, LLC
- A process and chromatography material for chromatography recovery of nucleic acid molecules15 Jan 2026US 2026/0015603 A1Cytiva BioProcess R&D AB
- Direct affinity to size-exclusion chromatography methods and systems thereof30 Oct 2025US 2025/0332526 A1Waters Technologies Corporation
- Relative potency assay for viral vector encoding isomerohydrolases2 Oct 2025US 2025/0305024 A1Spark Therapeutics, Inc.
- Methods for ethanol-free mrna purification27 Mar 2025US 2025/0101408 A1Sanofi
Most cited
By later US patents
- Biomolecule sample immobilization41US 5,124,041 AApplied Biosystems, LLC · 1992
- Purification platform for bispecific antibodies32US 10,626,142 B2Regeneron Pharmaceuticals, Inc. · 2020
- Process for producing biologically active factors8US 4,621,055 A1986
- Chromatography medium3US 10,850,259 B2Puridify Ltd. · 2020
- Alkyl-linked nucleotide compositions3US 7,371,852 B2Serenex, Inc. · 2008